Verition Fund Management Portfolio holdings
AUM
$17.4B
1-Year Return
15.18%
This Quarter Return
-2.28%
1 Year Return
+15.18%
3 Year Return
+52.88%
5 Year Return
+61.62%
10 Year Return
+138.21%
AUM
$17.4B
AUM Growth
-$2.45B
(-12%)
Cap. Flow
-$2.01B
Cap. Flow
% of AUM
-11.57%
Top 10 Holdings %
Top 10 Hldgs %
18.37%
Holding
3,015
New
460
Increased
1,103
Reduced
970
Closed
377
Top Buys
| 1 |
Amazon
AMZN
|
+$170M |
| 2 |
Consolidated Edison
ED
|
+$62.3M |
| 3 |
Cenovus Energy
CVE
|
+$62.3M |
| 4 |
Royal Gold
RGLD
|
+$57.6M |
| 5 |
NVIDIA
NVDA
|
+$56.4M |
Top Sells
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$361M |
| 2 |
TSMC
TSM
|
+$258M |
| 3 |
Apple
AAPL
|
+$247M |
| 4 |
SPDR S&P 500 ETF Trust
SPY
|
+$144M |
| 5 |
Arthur J. Gallagher & Co
AJG
|
+$108M |
Sector Composition
| 1 | Technology | 16.08% |
| 2 | Financials | 15.41% |
| 3 | Consumer Discretionary | 15.05% |
| 4 | Industrials | 10.2% |
| 5 | Healthcare | 7.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1676
Ormat Technologies
ORA
$5.53B
| $854K | ﹤0.01% |
12,067
-2,430
| -17% | -$172K |
|
1677
AMN Healthcare
AMN
$699M
| $854K | ﹤0.01% |
+34,904
| New | +$854K |
|
1678
Waters Corp
WAT
$17.6B
| $853K | ﹤0.01% |
2,314
+1,170
| +102% | +$431K |
|
1679
HEICO Class A
HEI.A
$34.9B
| $852K | ﹤0.01% |
4,040
| – | – |
|
1680
Global Ship Lease
GSL
$1.14B
| $850K | ﹤0.01% |
37,178
+4,712
| +15% | +$108K |
|
1681
Delek US
DK
$1.68B
| $849K | ﹤0.01% |
56,343
-32,267
| -36% | -$486K |
|
1682
BBB Foods
TBBB
$3B
| $849K | ﹤0.01% |
31,810
+17,592
| +124% | +$469K |
|
1683
Match Group
MTCH
$9.08B
| $847K | ﹤0.01% |
27,151
-28,160
| -51% | -$879K |
|
|
EH
1684
EHang Holdings
EH
$1.19B
| $846K | ﹤0.01% |
+40,520
| New | +$846K |
|
1685
Eastman Chemical
EMN
$7.71B
| $845K | ﹤0.01% |
9,595
-90,922
| -90% | -$8.01M |
|
1686
First Majestic Silver
AG
$5.15B
| $840K | ﹤0.01% |
+125,618
| New | +$840K |
|
|
MAV
1687
DELISTED
Pioneer Municipal High Income Advantage Fund
MAV
| $839K | ﹤0.01% |
+100,504
| New | +$839K |
|
1688
Ibotta
IBTA
$756M
| $838K | ﹤0.01% |
+19,854
| New | +$838K |
|
1689
Repligen
RGEN
$6.39B
| $835K | ﹤0.01% |
6,565
-5,231
| -44% | -$666K |
|
1690
GlobalFoundries
GFS
$17.6B
| $834K | ﹤0.01% |
22,603
+2,618
| +13% | +$96.6K |
|
1691
AstraZeneca
AZN
$247B
| $829K | ﹤0.01% |
11,277
+5,718
| +103% | +$420K |
|
1692
NCR Voyix
VYX
$1.77B
| $827K | ﹤0.01% |
84,818
+62,440
| +279% | +$609K |
|
1693
Hercules Capital
HTGC
$3.53B
| $824K | ﹤0.01% |
+42,900
| New | +$824K |
|
1694
Community Health Systems
CYH
$412M
| $823K | ﹤0.01% |
304,698
+113,202
| +59% | +$306K |
|
1695
Baker Hughes
BKR
$45.8B
| $820K | ﹤0.01% |
18,647
-245,264
| -93% | -$10.8M |
|
1696
Ares Management
ARES
$40.1B
| $818K | ﹤0.01% |
5,582
+1,820
| +48% | +$267K |
|
1697
Kymera Therapeutics
KYMR
$3.36B
| $818K | ﹤0.01% |
29,890
+24,543
| +459% | +$672K |
|
1698
LendingTree
TREE
$978M
| $817K | ﹤0.01% |
16,255
-16,971
| -51% | -$853K |
|
1699
Agios Pharmaceuticals
AGIO
$2.14B
| $813K | ﹤0.01% |
27,753
-19,072
| -41% | -$559K |
|
1700
MaxLinear
MXL
$1.37B
| $813K | ﹤0.01% |
74,870
+10,540
| +16% | +$114K |
|